Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Julve

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 2011
Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutationJesús M Martín-Campos, Rosa Roig, Carme Mayoral, et al.
Antioxidants (Basel, Switzerland)|May 27, 2023
Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14Lucía Sanjurjo, Esmeralda Castelblanco, Josep Julve, et al.
Journal of Lipid Research|October 5, 2002
Mechanisms of HDL deficiency in mice overexpressing human apoA-IIJosep Julve, Joan Carles Escolà-Gil, Vicent Ribas, et al.
Biochimica Et Biophysica Acta|January 19, 2013
Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant propertiesJoan Carles Escolà-Gil, Xiangyu Chen, Josep Julve, et al.
Metabolism: Clinical and Experimental|August 5, 2003
Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretionAna M Wägner, Jordi Ordóñez-Llanos, Rosa Arcelus, et al.
Biochimica Et Biophysica Acta|December 4, 2010
Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivoNoemí Rotllan, Gemma Llaverías, Josep Julve, et al.
Atherosclerosis|February 21, 2019
Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patientsFrancisco Blanco-Vaca, Jesús M Martin-Campos, Ángel Beteta-Vicente, et al.
Journal of Lipid Research|January 17, 2002
ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemiaJesús M Martín-Campos, Josep Julve, Joan Carles Escolà, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|August 14, 2013
[Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice]Josep Julve, Teresa Laura Errico, Xiangyu Chen, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 14, 2012
Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivoJoan Carles Escolà-Gil, Josep Julve, Gemma Llaverias, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 2011
Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutationJesús M Martín-Campos, Rosa Roig, Carme Mayoral, et al.
Antioxidants (Basel, Switzerland)|May 27, 2023
Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14Lucía Sanjurjo, Esmeralda Castelblanco, Josep Julve, et al.
Journal of Lipid Research|October 5, 2002
Mechanisms of HDL deficiency in mice overexpressing human apoA-IIJosep Julve, Joan Carles Escolà-Gil, Vicent Ribas, et al.
Biochimica Et Biophysica Acta|January 19, 2013
Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant propertiesJoan Carles Escolà-Gil, Xiangyu Chen, Josep Julve, et al.
Metabolism: Clinical and Experimental|August 5, 2003
Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretionAna M Wägner, Jordi Ordóñez-Llanos, Rosa Arcelus, et al.
Biochimica Et Biophysica Acta|December 4, 2010
Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivoNoemí Rotllan, Gemma Llaverías, Josep Julve, et al.
Atherosclerosis|February 21, 2019
Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patientsFrancisco Blanco-Vaca, Jesús M Martin-Campos, Ángel Beteta-Vicente, et al.
Journal of Lipid Research|January 17, 2002
ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemiaJesús M Martín-Campos, Josep Julve, Joan Carles Escolà, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|August 14, 2013
[Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice]Josep Julve, Teresa Laura Errico, Xiangyu Chen, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 14, 2012
Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivoJoan Carles Escolà-Gil, Josep Julve, Gemma Llaverias, et al.
Pageof 13